Relationship between immune gene signatures and clinical response to PD-1 blockade with pembrolizumab (MK-3475) in patients with advanced solid tumors. (4th November 2015) - Ayers, Mark; Lunceford, Jared; Nebozhyn, Michael; Murphy, Erin; Loboda, Andrey; Albright, Andrew; Cheng, Jonathan; Kang, S Peter; Ebbinghaus, Scot; Yearley, Jennifer; Shankaran, Veena; Seiwert, Tanguy; et al.